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Abstract:
Bisphenol A (BPA) is an organic, solid substance that is structurally similar to estradiol, a
naturally-occurring form of the female sex hormone estrogen. Since the 1957 discovery that BPA
can function as an effective hardener, BPA-based plastics have been used to make a variety of
consumer goods, such as water bottles, baby bottles, DVDs, eyeglass lenses, and medical devices,
while BPA-based epoxy resins have been used to coat the insides of various food and drink
containers, to line the insides of water pipes, and to create the thermal ink found on paper sales
receipts. In recent years, however, numerous studies have suggested that BPA-exposure during
fetal growth and childhood can lead to later problems like obesity, type 1 diabetes, anxiety,
depression, hyperactivity, and aggression. While BPA has already been banned from baby bottles,
no BPA regulations have been placed on children's oral hygiene devices as of yet. Some infant
oral hygiene devices like toothbrushes claim to be BPA-free, while others do not make any
statements regarding BPA content. In this research study, a technique was developed to
determine the presence of BPA in toothbrushes made for infants and toddlers using fluorescence
spectrophotometry. Using this technique, two different types of toothbrushes were analyzed :
those labeled BPA-free and those not labeled. It was found that neither toothbrushes showed
traces of BPA, although the toothbrush with no label showed an upward trend in regards to
emission intensity that could possibly show the presence of BPA if more time was given in the
solvent. This thesis will discuss literature detailing the effects of BPA on infant health, the results
of the fluorescence spectrophotometry study done on the toothbrushes, and future research
that can be done to both enhance the current study and further the exploration of BPA-exposure
in infants.

Introduction:
BPA Background

BPA was first created in 1891 by Russian chemist Aleksandr Pavlovich Dian in as a side product of
the catalyzed condensation reaction of a two-to-one mixture of phenol and acetone in
concentrated hydrochloric acid (Figure 1). 1' 2
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Figure 1. The synthesis of BPA from two phenol molecules and one acetone molecule.

In 1938, a British chemist by the name of Edward Charles Dodds discovered that BPA and
estradiol, a naturally-occurring form of the estrogen hormone, shared similar chemical
features-namely their phenol groups

OH

OH

(Figure 2). 2' 3 He soon began developing
BPA to be a form of synthetic estrogen,
although this endeavor was short-term,
as another compound was found to

HO
produce better results. Interestingly, this
compound would be later banned by the
FDA in 1979 as it was found to be linked
to rare vaginal cancers. 3

H3 c'··
••
HO'
E tradiol

Figure 2. The chemical structures of BPA and estradiol, with the
blue regions showing the structural similarities.

Less than twenty years later, however, one discovery would drastically change the
applications of BPA forever. In 1953, chemists Dr. Hermann Schnell of Bayer and Dr. Daniel Fox
of General Electric independently discovered how to use BPA to create a hard resin called
polycarbonate by combining BPA with
+

phosgene (Figure 3). 4 This hard resin
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was clear and rigid like glass, although
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much lighter and shatter-resistant. It
was also more affordable than glass
and thus easier to replace if broken .
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Figure 3. The reaction of BPA and phosgene in basic solution results in
the formation of polycarbonate, a strong plastic used in many
consumer good.

connectors. 4 In the 1960s, the Food and Drug Administration (FDA) approved polycarbonate to
be used in food packaging, and it was this that launched a world-wide boom in BPA-exposure. 4
BPA became increasingly popular in consumer goods, and the estrogenic properties
revealed by Dodds were ignored for nearly thirty years. This would soon change, however, in
1993, when Dr. David Feldman, a medical doctor and Stanford University professor discovered
the leaching properties of BPA. 4 In a study to find estrogen-producing yeast, Feldman and his
team were growing yeast in plastic flasks and noticed an estrogenic molecule in the growth
medium. 5 After isolating the molecule and analyzing it with the use of nuclear magnetic
resonance spectroscopy and mass spectroscopy, the team found that the molecule was BPA. 5
Successive testing done using flasks containing only distilled water showed that the presence of

BPA was not dependent on either the yeast or the growth medium. 5 This also disproved that the
BPA was being synthesized by the yeast. Feldman and his team then repeated the studies using
glass flasks in place of plastic and found no traces of BPA. 5 These findings led to the conclusion
that BPA was being leached from the polycarbonate plastic and into the contents of the flask
during the heating of the autoclaving process. 5 Also alarming was the revelation that BPA could
bind to the estrogen receptors in rat uterus, as Feldman and his team discovered, which indicated
that BPA was not just a form of synthetic estrogen but also an endocrine disruptor. 5

BPA as an Endocrine Disruptor

Endocrine disruptors are chemicals that hinder the normal functioning of the endocrine
system, usually by interfering with hormones. The most common way is through competitive
inhibition (Figure 4). In this mechanism, the
endocrine disrupter binds to a hormone
receptor, thus inhibiting the hormone from
binding and initiating its normal response.
BPA acts as an endocrine disrupter
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to the two types of estrogen receptors
(ERs):

ERa

and

ER/3 .6 Both

of these

receptors are ligand-activated, meaning
that the binding of a ligand (i.e., estrogen)
causes them to undergo a change in

Figure 4. An endocrine disrupter exhibiting competitive
inhibition.

conformation. 6 After this shape change, the receptors are able to migrate into the nucleus of the

cell. It is here that the ERs act as transcription factors, interacting with activators and repressors
associated with the target gene. If a transcription factor binds to an activator, the expression of
the target gene increases, while the binding of a transcription factor to a repressor causes the
expression to decrease.
Because the structural configuration of BPA is so similar to that of estrogen, the body is
unable to distinguish between the two. As a result, BPA is able to successfully bind to both ERa
and ER/3. However, because BPA and estrogen are not identical, the binding of BPA causes each
type of ER to undergo a different conformation change. 6 When BPA binds to ERa, the receptor
undergoes the same conformation change as would normally occur with estrogen as the ligand.
Therefore, BPA acts agonistically to ERa, meaning that the binding of BPA to ERa initiates the
same types of responses in the body as would occur if there were high levels of estrogen present,
thus increasing estrogenic-related activities. On the other hand, the binding of BPA to ER/3 causes
an alteration in the receptor's conformation change, resulting in no response to occur. In this
way, BPA acts antagonistically to ER/3, meaning that the binding of BPA to ER/3 mimics that of
having no estrogen present in the body, thus inhibiting estrogenic-related activities.

Effects of BPA on the Bodv

Although the discovery ofthe harmful nature of BPA is relatively recent, numerous studies
have already been performed concerning the health risks of BPA exposure. In a study done by
Kristin Junge and team, prenatal BPA exposure was found to be linked to obesity. 7 In this study,
408 infants were analyzed based on the levels of BPA they had been exposed to during prenatal
development, as was determined by urine samples from the mothers. At birth, cord blood

samples were taken from these infants, and the DNA methylation of these samples was
measured using MassARRAY. The results revealed that infants exposed to higher levels of BPA
during prenatal development
showed decreased methylation
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Figure 5. The methylation of CpG islands greatly controls transcription.

short segments of DNA that precede promoters, and the degree of methylation at these regions
partly dictates whether a gene can be transcribed into RNA (Figure 5). When the CpG islands of
a particular gene are highly methylated, transcription factors are unable to interact with the
promoter and cannot turn it on, thereby inhibiting the transcription of the gene. When the CpG
islands are unmethylated or hypomethylated, however, the promoter is more accessible to
transcription factors, allowing transcription to freely occur. The' MEST gene is said to control
adipocyte size and thus the development of adipose tissueJ When the CpG islands associated
with the MEST promoters are hypomethylated due to prenatal BPA-exposure, an increase in
MEST RNA expression occurs, resulting in the accumulation of large amounts of fat cells and fat
tissue. This increased MEST expression was found evident in the BMI studies conducted on the
infants at age one, which found that the infants who had been exposed to greater levels of BPA
during development showed higher BMI scores than their less-exposed cohorts. 7
BPA has also been linked to the development of type 1 diabetes. In a study performed by
Johanna Bodin and team, healthy weight, non-diabetic infant mice were administered doses of
BPA via drinking water (1 mg/L) over the course of 35 weeks--doses considered to be under the

Fluorescence Spectroscopy

Fluorescence is the light energy given off when a certain type of compound absorbs
energy, usually in the form of light or radiation. When the electrons in a fluorescent compound
absorb a specific wavelength of energy, they become excited and begin to vibrate, moving from
their ground energy state to a higher energy state. In fluorescence spectroscopy, the compound
is excited by photons of light, causing the electrons to transition to a higher energy state. The
electrons remain in this higher energy state for a short period of time, approximately 10-8-10- 4
seconds, before then losing energy
and returning back to their ground
~

state. The lost energy is released in
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the form of fluorescence (Figure 6).
Because this emitted energy is less
than the initial absorbed photon
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Figure 6. Jablonski energy diagram illustrating fluorescence.

energy, the wavelength ofthe emitted fluorescent light is greater, due to the inverse relationship
between energy and wavelength.
The wavelength of the emitted fluorescence is unique for every compound. Previous
research
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Figure B. Excitation and emission spectra of BPA in methanol water.

presence of BPA in a sample by examining the wavelengths of the emitted fluorescence. If a
sample contains BPA, the emission
wavelengths will be 310 nm when
excited by wavelengths of 278 nm.
This

can

fluorescence

be

tested

using

a

spectrophotometer

(Figure 9). Within this instrument, a

Figure 9. The mechanism of a fluorescence spectrophotometer.

light source is emitted onto a prism and then a filter, which separates the light into a specified
wavelength (278 nm, in this case). This specific wavelength is then directed to the sample, which
is contained within a quartz cuvette. The electrons in the sample will become excited, travel to
an increased energy state, and then release light energy on their way back to their ground state,
as previously mentioned. This emitted light is passed through a detector, which records the
wavelength. If the sample contains BPA, this wavelength will be approximately 310 nm.

Materials and Methods:
In order to become familiarized
with the instrument and to set a
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Figure 10. Fluorescence calibration curve of BPA.
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made using 0 ml, 2 ml, 4 ml, and 6 ml of BPA, respectively. All concentrations were run in
triplicates.
To begin the study, two toothbrushes designed for infants and toddlers were obtained:
one labeled BPA-free (Toothbrush A) and one with no label (Toothbrush B). Each toothbrush was
placed in separate 100-ml beakers containing 100 ml of Milli-Q water. Over the course of one
week, 10-ml aliquots of the Milli-Q water were taken from each beaker at various times and
placed in 10-ml volumetric flasks. On the starting day ofthe experiment, samples were taken at
the onset (time= 0 hours) and then every twenty minutes for two hours (time= 0.33, 0.66, 1.00,
1.33, 1.66 hours). Samples were then taken every twenty-four hours for three days (time = 24,
48, 72 hours) and then once more on the seventh day (time= 168 hours). For control, two 10-ml
samples of Milli-Q water were taken at the start of the experiment (time = 0 hours). Samples
were analyzed using the FS-5 Spectrofluorometer from Edinburgh Instruments. A portion of each
sample was pipetted into the quartz cuvette, which was then placed into the instrument. The
parameters of the instrument were set to include excitation wavelengths of 278 nm and emission
wavelengths of 310 nm. Samples were done in triplicates, with thorough washings between each.

Results and Discussion:
For all samples, the following values were recorded: emission wavelength, emission
intensity, excitation wavelength, and excitation intensity (Tables 1 & 2).

Toothbrush Labeled BPA-Free

Time of
Absorbance
(Hours)

Emission
Wavelength

Emission Intensity
(counts/10A3)

Excitation
Wavelength

Excitation Intensity
(counts/10A3)

0

308

267

281

126.3

0.33

308

0.67

307

1

307

1.33

308

1.67

307

24

307

48

307

72

307

168

308

I
l
I
l
l
l
l

239

l

280

168

I
I
I

280

171

I

280

173

I

280

156

I

280

158
154

192

I

181

Table 1. Fluorescence spectrophotometry results for Toothbrush A.

I

281
280

280
280

l
l
I
l
l
l
I
l
I

142.7
89.96
90.42
81.56
93.55
86.36
85.76
98.35
97.75

Toothbrush Not Labeled

Time of
Absorbance
(Hours)

Emission
Wavelength

Emission Intensity
(counts/10A3)

Excitation
Wavelength

Excitation Intensity
(counts/10A3)

0

308

137

280

65.97

0.33

307

0.67

306

1

308

1.33

307

1.67

307

24

308

48

308

72

307

168

307

I

I
I
I
I
I
l

166
130
165
158
141
151
140

I
I
I
I
I

280

I

279

I

149

I

190

Table 2. Fluorescence spectrophotometry results for Toothbrush B.
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The toothbrush labeled BPA-free (Toothbrush A) did not show traces of BPA. The
toothbrush with no label also did not show traces of BPA (Toothbrush B), although the line did
exhibit an upward progression that could possibly reveal BPA if given more time.

Summary and Conclusions:
Bisphenol A is a very prevalent molecule, as it has been used in the widespread
manufacturing of consumer goods since the 1960s. However, recent research suggests that BPA
exposure is harmful, as the molecule binds to estrogen receptors in the body and elicits a number
of estrogenic responses. This is particularly true for infants and children, as they do not have a
well-developed purification system like adults. Studies show that BPA exposure during
development leads to increased MEST gene expression, which can result in higher BMI scores
and thus an increased risk of obesity. Exposure to BPA has also been linked to type 1 diabetes, as
BPA depletes phagocytic macrophages that serve to lessen hyperglycemia and insulitis.
Furthermore, infants are being exposed to BPA in many ways, including through the intake of
both liquid and formula formulas, and by contact with medical devices like those found in the
neonatal intensive care unit. In 2012, BPA-based plastics were banned from being used in the
manufacturing of baby bottles. However, no BPA regulations have been places on oral hygiene
devices made for children .
In this study, I wanted to determine if BPA was present in toothbrushes designed for
children. I also wished to see if the toothbrushes labeled BPA-free were truly void of BPA. This
was an unexplored field, so I first had to design a way to test the toothbrushes for BPA. I then
used fluorescence spectrophotometry to determine the presence of BPA.

Future Work:

In this study, only a single BPA-free labeled toothbrush and a single non-labeled toothbrush were
tested. Therefore, to get a better understanding of BPA leaching from infant toothbrushes, it
would be ideal to perform this experiment again with a variety of different brands and styles.
Furthermore, many infants and toddlers drink a wide variety offruit juices (i.e., apple juice, white
grape juice, orange juice). For this reason, it would be interesting to determine to what effect the
acidity ofthese different juices would have on BPA leaching, if any at all. In addition, a gentleman
at the research conference where I presented inquired about the Milli-Q water that I used. He
noted that the purity of this water could possibly be inhibiting the leaching of BPA from the
toothbrush, as there are no impurities for the BPA molecules to interact with .
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